25 May 2013
Keywords: hivid, approved, monotherapy, usa, food, drug, administ-ration
Article | 15 August 1994
The US Food and Drug Administ-ration has approved the marketing of
Hoffmann-La Roche's Hivid (zalcitabine) as a monotherapy treatment for
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
15 August 1994
25 July 1994
24 May 2013
© 2013 thepharmaletter.com